Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02076438 · ClinicalTrials.gov registry record · NA
Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT02076438: Clinical Trial NA study, sponsored by Rutgers, The State University of New Jersey.
NCT02076438 is a NA study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02076438, a NA study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The study will evaluate if administration of probiotic Culturelle (Lactobacillus Rhamnosus GG) along with antibiotics can help decrease the occurrence of diarrhea caused by antibiotics as well as Clostridium difficile Diarrhea.
Primary Outcome
Diarrhea associated with antibiotics
Interventions
- DIETARY_SUPPLEMENT Probiotics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-09 |
| Phase | NA |
Why NCT02076438 stopped before completion
NCT02076438 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Probiotics is the first listed.
NCT02076438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02076438 about?
NCT02076438 is a clinical study titled "Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease". The study will evaluate if administration of probiotic Culturelle (Lactobacillus Rhamnosus GG) along with antibiotics can help decrease the occurrence of diarrhea caused by antibiotics as well as Clostridium difficile Diarrhea.
What is the current status of trial NCT02076438?
This trial is currently terminated. It is a NA study. The enrollment target is 110 participants. The study started on 2015-11. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02076438?
The interventions under investigation include: Probiotics (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02076438?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02076438's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia